Search

Search results

56 results found

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.

Tischkowitz, Marc, Nancy Hamel, Marcelo A Carvalho, Gabriel Birrane, Aditi Soni, Erik H van Beers, Simon A Joosse, et al. 2008. “Pathogenicity of the BRCA1 Missense Variant M1775K Is Determined by the Disruption of the BRCT Phosphopeptide-Binding Pocket: A Multi-Modal Approach.”. European Journal of Human Genetics : EJHG 16 (7): 820-32.